List view / Grid view
15 November 2012 | By Janssen Global Services
Lilly and Merck are first to join Janssen in this pre-competitive initiative to increase efficiencies in clinical trials...
15 November 2012 | By Gilead Sciences
Two-year results announced ...
14 November 2012 | By Sanofi
Sanofi is pleased to announce the appointment of Dr. Gary J. Nabel...
14 November 2012 | By GlaxoSmithKline
“GSK has been collaborating with the U.S. Department of Health and Human Services..."
14 November 2012 | By AstraZeneca
The European Commission has approved FORXIGA™ (dapagliflozin) tablets...
14 November 2012 | By
Collaboratation on the TEENs registry study...
14 November 2012 | By Novo Nordisk
Novo Nordisk has for the second year in a row just been ranked among the top 25 best multinational workplaces...
14 November 2012 | By Boehringer Ingelheim
Today sees the culmination of weeklong activities at Boehringer Ingelheim...
14 November 2012 | By Novo Nordisk
New numbers on the prevalence of diabetes have been launched...
13 November 2012 | By Boehringer Ingelheim
Boehringer Ingelheim and BaroFold, Inc, have entered into a non-exclusive technology and commercial license option agreement...
13 November 2012 | By Abbott
Details on its phase 3 hepatitis C registrational program...
13 November 2012 | By GlaxoSmithKline
24-week data from VIKING-3 Phase III study...
13 November 2012 | By AstraZeneca
Court in Germany has found the formulation patent protecting SEROQUEL XR® prolonged-release tablets to be invalid...
13 November 2012 | By Catalent Pharma Solutions
Deal follows study which achieved record yield for human alpha-1 antitrypsin (hAAT) molecule...
12 November 2012 | By Amgen
Amgen and Pfizer announced that results from several Enbrel® (etanercept) studies...
